Next Generation Kinase Inhibitors: Moving Beyond the ATP Binding/Catalytic Sites
 
A termék adatai:

ISBN13:9783030482824
ISBN10:30304828211
Kötéstípus:Keménykötés
Terjedelem:217 oldal
Méret:235x155 mm
Súly:518 g
Nyelv:angol
Illusztrációk: 3 Illustrations, black & white; 56 Illustrations, color
221
Témakör:

Next Generation Kinase Inhibitors

Moving Beyond the ATP Binding/Catalytic Sites
 
Kiadás sorszáma: 1st ed. 2020
Kiadó: Springer
Megjelenés dátuma:
Kötetek száma: 1 pieces, Book
 
Normál ár:

Kiadói listaár:
EUR 139.09
Becsült forint ár:
57 395 Ft (54 662 Ft + 5% áfa)
Miért becsült?
 
Az Ön ára:

45 916 (43 730 Ft + 5% áfa )
Kedvezmény(ek): 20% (kb. 11 479 Ft)
A kedvezmény érvényes eddig: 2024. június 30.
A kedvezmény csak az 'Értesítés a kedvenc témákról' hírlevelünk címzettjeinek rendeléseire érvényes.
Kattintson ide a feliratkozáshoz
 
Beszerezhetőség:

Becsült beszerzési idő: A Prosperónál jelenleg nincsen raktáron, de a kiadónál igen. Beszerzés kb. 3-5 hét..
A Prosperónál jelenleg nincsen raktáron.
Nem tudnak pontosabbat?
 
  példányt

 
Rövid leírás:

Protein kinases are fascinating enzymes that maintain the proper function of nearly every task performed by the cells of the human body. By extracting a phosphate from the energy molecule ATP and linking it to another protein, protein kinases alter the structure and ultimate function of other proteins. In this way, protein kinases help monitor the extracellular environment and integrate signaling cues that, for the most part, are beneficial for human health and survival. However, protein kinases are often dysregulated and responsible for the initiation and progression of many types of cancers, inflammatory disorders, and other diseases. Thus, decades of research have revealed much about how protein kinases are regulated and approaches to inhibit these enzymes to treat disease. However, nearly 30 years since the identification of the first clinically beneficial small molecule protein kinase inhibitor, there are only a few examples where these drugs provide sustained and durable patient responses. The goal of this book is to provide biomedical scientists, graduate, and professional degree students insight into different approaches using small molecules to block specific protein kinase functions that promote disease. 

Hosszú leírás:
Protein kinases are fascinating enzymes that maintain the proper function of nearly every task performed by the cells of the human body. By extracting a phosphate from the energy molecule ATP and linking it to another protein, protein kinases alter the structure and ultimate function of other proteins. In this way, protein kinases help monitor the extracellular environment and integrate signaling cues that, for the most part, are beneficial for human health and survival. However, protein kinases are often dysregulated and responsible for the initiation and progression of many types of cancers, inflammatory disorders, and other diseases. Thus, decades of research have revealed much about how protein kinases are regulated and approaches to inhibit these enzymes to treat disease. However, nearly 30 years since the identification of the first clinically beneficial small molecule protein kinase inhibitor, there are only a few examples where these drugs provide sustained and durable patient responses. The goal of this book is to provide biomedical scientists, graduate, and professional degree students insight into different approaches using small molecules to block specific protein kinase functions that promote disease. 
Tartalomjegyzék:

Chapter 1: Introduction to Kinases, Cellular Signaling, and Kinase Inhibitors. [Paul Shapiro et al.]



Chapter 2: Overview of Current Type I/II Kinase Inhibitors. [Zheng Zhao, Philip E. Bourne]



Chapter 3: Avoiding or Co-opting ATP Inhibition: Type III, IV, V, and VI Kinase Inhibitors. [Paul Shapiro et al]



Chapter 4: Structural Features Regulating Kinase Interactions with Regulatory and Substrate Proteins. [Paul Shapiro et al.]



Chapter 5: Developing Kinase Inhibitors using Computer-Aided Drug Design Approaches [Yu et al.]



Chapter 6: A Toolbox of Structural Biology and Enzyme Kinetics Reveals the Case for ERK Docking Site Inhibition [Rachel Sammons and Kevin Dalby]



Chapter 7: Novel Stabilized Peptide Inhibitors of Protein Kinases (Helton et al.)



Chapter 8: Novel peptide-based inhibitors of protein kinases [Justin Holub]